Cargando…
Single-domain antibody screening by isPLA-seq
Single-domain antibody (sdAb) holds the promising strategies for diverse research and translational applications. Here, we describe a method for the adaptation of the in situ proximity ligation assay (isPLA) followed by sequencing (isPLA-seq) to facilitate screening of a high-sensitive, high-through...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548206/ https://www.ncbi.nlm.nih.gov/pubmed/34675071 http://dx.doi.org/10.26508/lsa.202101115 |
_version_ | 1784590526396235776 |
---|---|
author | Yin, Yueyuan Yan, Fei Zhou, Ruimin Li, Mingchen Ma, Jinyi Liu, Zhe Ma, Zhenyi |
author_facet | Yin, Yueyuan Yan, Fei Zhou, Ruimin Li, Mingchen Ma, Jinyi Liu, Zhe Ma, Zhenyi |
author_sort | Yin, Yueyuan |
collection | PubMed |
description | Single-domain antibody (sdAb) holds the promising strategies for diverse research and translational applications. Here, we describe a method for the adaptation of the in situ proximity ligation assay (isPLA) followed by sequencing (isPLA-seq) to facilitate screening of a high-sensitive, high-throughput sdAb library for a given protein at subcellular and single-cell resolution. Based on the sequence of complementarity-determining region 3 (CDR3), the recombinant sdAb can be produced for in vitro and in vivo utilities. This method provides a general means to identify the functional measure of sdAb and its complementary epitopes and its potential applications to investigate cellular processes. |
format | Online Article Text |
id | pubmed-8548206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Life Science Alliance LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-85482062021-11-05 Single-domain antibody screening by isPLA-seq Yin, Yueyuan Yan, Fei Zhou, Ruimin Li, Mingchen Ma, Jinyi Liu, Zhe Ma, Zhenyi Life Sci Alliance Research Articles Single-domain antibody (sdAb) holds the promising strategies for diverse research and translational applications. Here, we describe a method for the adaptation of the in situ proximity ligation assay (isPLA) followed by sequencing (isPLA-seq) to facilitate screening of a high-sensitive, high-throughput sdAb library for a given protein at subcellular and single-cell resolution. Based on the sequence of complementarity-determining region 3 (CDR3), the recombinant sdAb can be produced for in vitro and in vivo utilities. This method provides a general means to identify the functional measure of sdAb and its complementary epitopes and its potential applications to investigate cellular processes. Life Science Alliance LLC 2021-10-21 /pmc/articles/PMC8548206/ /pubmed/34675071 http://dx.doi.org/10.26508/lsa.202101115 Text en © 2021 Yin et al. https://creativecommons.org/licenses/by/4.0/This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Articles Yin, Yueyuan Yan, Fei Zhou, Ruimin Li, Mingchen Ma, Jinyi Liu, Zhe Ma, Zhenyi Single-domain antibody screening by isPLA-seq |
title | Single-domain antibody screening by isPLA-seq |
title_full | Single-domain antibody screening by isPLA-seq |
title_fullStr | Single-domain antibody screening by isPLA-seq |
title_full_unstemmed | Single-domain antibody screening by isPLA-seq |
title_short | Single-domain antibody screening by isPLA-seq |
title_sort | single-domain antibody screening by ispla-seq |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548206/ https://www.ncbi.nlm.nih.gov/pubmed/34675071 http://dx.doi.org/10.26508/lsa.202101115 |
work_keys_str_mv | AT yinyueyuan singledomainantibodyscreeningbyisplaseq AT yanfei singledomainantibodyscreeningbyisplaseq AT zhouruimin singledomainantibodyscreeningbyisplaseq AT limingchen singledomainantibodyscreeningbyisplaseq AT majinyi singledomainantibodyscreeningbyisplaseq AT liuzhe singledomainantibodyscreeningbyisplaseq AT mazhenyi singledomainantibodyscreeningbyisplaseq |